Chimeric and humanised monoclonal antibodies against Inteleukin13

Details for Australian Patent Application No. 2005259025 (hide)

Owner Glaxo Group Limited

Inventors Ashman, Claire; Ellis, Jonathan Henry; Cassidy, Martin John; Wattam, Trevor Anthony Kenneth

Agent Davies Collison Cave

Pub. Number AU-B-2005259025

PCT Pub. Number WO2006/003407

Priority 0423675.8 25.10.04 GB; 0414799.7 01.07.04 GB

Filing date 30 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 19 January 2012

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/003407 Priority application(s): WO2006/003407

19 January 2012 Application Accepted

  Published as AU-B-2005259025

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259028-A dispenser tap with two stage valve

2005259012-Analyte detection system